The Walt Disney Company (a Delaware corporation) Fixed Rate Medium-Term Notes, Series F TERMS AGREEMENT
Exhibit 1.1
The Xxxx Disney Company
(a Delaware corporation)
Fixed Rate
Medium-Term Notes, Series F
TERMS AGREEMENT
September 14, 2015
The Xxxx Disney Company
000 Xxxxx Xxxxx Xxxxx Xxxxxx
Xxxxxxx, Xxxxxxxxxx 00000
Attention: Legal Department
Re: Distribution Agreement dated December 6, 2013
Reference is made to the Distribution Agreement dated December 6, 2013 (the “Distribution Agreement”) among The Xxxx Disney Company, a Delaware corporation (the “Company”), and the other parties thereto, which is incorporated herein by reference. The several underwriters named below (the “Underwriters”) severally agree to purchase the following respective principal amounts of Medium-Term Notes, Series F, entitled 1.500% Notes Due 2018 (the “2018 Notes”), 2.150% Notes Due 2020 (the “2020 Notes”) and the 3.150% Notes Due 2025 (the “2025 Notes” and, together with the 2018 Notes and 2020 Notes, the “Notes”) set forth opposite their names:
Underwriter |
|
Principal |
|
Principal |
|
Principal |
| |||
Xxxxxxx, Sachs & Co. |
|
$ |
106,250,000 |
|
$ |
159,375,000 |
|
$ |
159,375,000 |
|
X.X. Xxxxxx Securities LLC |
|
106,250,000 |
|
159,375,000 |
|
159,375,000 |
| |||
BNP Paribas Securities Corp. |
|
106,250,000 |
|
159,375,000 |
|
159,375,000 |
| |||
Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx |
|
106,250,000 |
|
159,375,000 |
|
159,375,000 |
| |||
Lloyds Securities Inc. |
|
12,500,000 |
|
18,750,000 |
|
18,750,000 |
| |||
SMBC Nikko Securities America, Inc. |
|
12,500,000 |
|
18,750,000 |
|
18,750,000 |
| |||
U.S. Bancorp Investments, Inc. |
|
12,500,000 |
|
18,750,000 |
|
18,750,000 |
| |||
The Xxxxxxxx Capital Group, L.P. |
|
12,500,000 |
|
18,750,000 |
|
18,750,000 |
| |||
Xxxxxx & Company |
|
6,250,000 |
|
9,375,000 |
|
9,375,000 |
| |||
Lebenthal & Co., LLC |
|
6,250,000 |
|
9,375,000 |
|
9,375,000 |
| |||
Xxxxxx X. Xxxxxxx & Company, Inc. |
|
6,250,000 |
|
9,375,000 |
|
9,375,000 |
| |||
Xxxxxxx Xxxxxxxxx Xxxxx & Co., L.L.C. |
|
6,250,000 |
|
9,375,000 |
|
9,375,000 |
| |||
|
|
|
|
|
|
|
| |||
Total |
|
$ |
500,000,000 |
|
$ |
750,000,000 |
|
$ |
750,000,000 |
|
Stated Maturity Date: |
|
2018 Notes: September 17, 2018 |
|
|
2020 Notes: September 17, 2020 |
|
|
2025 Notes: September 17, 2025 |
|
|
|
Original Issue Date: |
|
September 17, 2015 |
|
|
|
Trade Date: |
|
September 14, 2015 |
|
|
|
Public Offering Price: |
|
2018 Notes: 99.915% plus accrued interest, if any, from September 17, 2015 |
|
|
2020 Notes: 99.750% plus accrued interest, if any, from September 17, 2015 |
|
|
2025 Notes: 99.762% plus accrued interest, if any, from September 17, 2015 |
|
|
|
Underwriting Discounts |
|
2018 Notes: 0.200% |
and Commissions: |
|
2020 Notes: 0.350% |
|
|
2025 Notes: 0.450% |
|
|
|
Price Payable to the |
|
2018 Notes: 99.715% |
Company by the |
|
2020 Notes: 99.400% |
Underwriters: |
|
2025 Notes: 99.312% |
|
|
|
Applicable Time: |
|
5:30 p.m. (New York City time) on September 14, 2015 |
|
|
|
Settlement Date and Time: |
|
September 17, 2015, at 7:00 a.m. Pacific Time |
|
|
|
Denominations: |
|
U.S. $2,000 or any integral multiple of U.S. $1,000 in excess of U.S. $2,000 |
|
|
|
Interest Rate: |
|
2018 Notes: 1.500% per annum, accruing from September 17, 2015 |
|
|
2020 Notes: 2.150% per annum, accruing from September 17, 2015 |
|
|
2025 Notes: 3.150% per annum, accruing from September 17, 2015 |
|
|
|
Interest Payment Dates: |
|
2018 Notes: Semi-annually on each March 17 and September 17, commencing on March 17, 2016 |
|
|
2020 Notes: Semi-annually on each March 17 and September 17, commencing on March 17, 2016 |
|
|
2025 Notes: Semi-annually on each March 17 and September 17, commencing on March 17, 2016 |
|
|
|
Day Count Convention: |
|
30/360 |
The Notes shall have the further terms set forth in Schedule II hereto.
The certificate referred to in Section 6(a) of the Distribution Agreement and the opinions referred to in Section 6(b) of the Distribution Agreement will not be required. The reasonable fees and disbursements of counsel to the Underwriters incurred in connection with the issuance and sale of the Notes will be paid by the Underwriters. On the Settlement Date referred to above, the Company shall deliver to the Underwriters a letter, dated the Original Issue Date referred to above and substantially in the form of Schedule I hereto.
Default by One or More of the Underwriters: If one or more of the Underwriters shall fail at the Original Issue Date referred to above to purchase the Notes which it or they are obligated to purchase under this Terms Agreement (the “Defaulted Notes”), the Representatives (as defined on the signature pages hereof) shall have the right, within 24 hours thereafter, to make arrangements for one or more of the non-defaulting Underwriters, or any other underwriters satisfactory to the Company, to purchase all, but not less than all, of the Defaulted Notes in such amounts as may be agreed upon and upon the terms herein set forth; if, however, the Representatives shall not have completed such arrangements within such 24-hour period, then:
(a) if the aggregate principal amount of the Defaulted Notes does not exceed 10% of the aggregate principal amount of the Notes to be purchased hereunder, the non-defaulting Underwriters shall be obligated, severally and not jointly, to purchase the full amount thereof in the respective proportions that their respective underwriting obligations hereunder bear to the underwriting obligations of all non-defaulting Underwriters, or
(b) if the aggregate principal amount of the Defaulted Notes exceeds 10% of the aggregate principal amount of the Notes to be purchased hereunder, this Terms Agreement shall terminate without liability on the part of any non-defaulting Underwriter.
No action taken pursuant to this paragraph shall relieve any defaulting Underwriter from liability in respect of its default.
In the event of any such default which does not result in a termination of this Terms Agreement, the Representatives or the Company shall have the right to postpone the Original Issue Date for a period not exceeding seven days in order to effect any required changes in the pricing supplement dated September 14, 2015 relating to the Notes or in any other documents or arrangements.
European Economic Area: In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a “Relevant Member State”), each Underwriter severally represents and agrees that with effect from and including the date on which the Prospectus Directive is implemented in that Relevant Member State (the “Relevant Implementation Date”) it has not made and will not make an offer of Notes which are the subject of the offering contemplated hereby to the public in that Relevant Member State except that it may, with effect from and including the Relevant Implementation Date, make an offer of such Notes to the public in that Relevant Member State at any time:
(a) to any legal entity which is a qualified investor as defined in the Prospectus Directive;
(b) to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Directive), subject to obtaining the prior consent of the Representatives for any such offer; or
(c) in any other circumstances falling within Article 3(2) of the Prospectus Directive,
provided that no such offer of Notes referred to in (a) through (c) above shall require the Company or any Underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Directive, or supplement a prospectus pursuant to Article 16 of the Prospectus Directive.
For the purposes of this provision, the expression an “offer of Notes to the public” in relation to any Notes in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the Notes to be offered so as to enable an investor to decide to purchase or subscribe for the Notes, as the same may be varied in that Relevant Member State by any measure implementing the Prospectus Directive in that Relevant Member State and the expression “Prospectus Directive” means Directive 2003/71/EC (and amendments thereto, including Directive 2010/73/EU) and includes any relevant implementing measure in the Relevant Member State.
United Kingdom: Each Underwriter severally represents and agrees that:
· it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Xxx 0000 (the “FSMA”)) received by it in connection with the issue or sale of the Notes in circumstances in which Section 21(1) of the FSMA does not apply to the Company; and
· it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the Notes in, from or otherwise involving the United Kingdom.
Each Underwriter severally represents to and agrees with the Company that it has not offered, sold or delivered and that it will not offer, sell or deliver, directly or indirectly, any of the Notes or distribute the pricing supplement and accompanying prospectus supplement and prospectus or any other material relating to the Notes, in or from any jurisdiction except under circumstances that will, to the best of its knowledge and belief, result in compliance with the applicable laws and regulations thereof.
Without prejudice to the other provisions of this Terms Agreement and the Distribution Agreement, and except for registration under the Securities Act of 1933, as amended, and compliance with the rules and regulations of the Securities and Exchange Commission thereunder, the Company shall not have any responsibility for, and each Underwriter severally agrees with the Company that such Underwriter and its respective affiliates will obtain, any consent, approval or authorization required by them for the subscription, offer, sale or delivery by them of any of the Notes under the laws and regulations in force in any foreign jurisdiction to which they are subject or in or from which they make such subscription, offer, sale or delivery of any of the Notes.
THIS TERMS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES CREATED HEREBY SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, INCLUDING WITHOUT LIMITATION, SECTIONS 5-1401 AND 5-1402 OF TITLE 14 OF THE NEW YORK GENERAL OBLIGATIONS LAW AND NEW YORK CIVIL PRACTICE LAW RULE 327(b).
If the foregoing is in accordance with your understanding of our agreement, please sign and return to the Representatives a counterpart hereof, whereupon this instrument along with all counterparts will become a binding agreement between the Company and the Underwriters in accordance with its terms.
|
Very truly yours, | |
|
| |
|
Xxxxxxx, Xxxxx & Co. | |
|
| |
|
By: |
/s/ Xxxx Xxxxxx |
|
|
Name: Xxxx Xxxxxx |
|
|
Title: Vice President |
|
| |
|
| |
|
X.X. Xxxxxx Securities LLC | |
|
| |
|
By: |
/s/ Xxxxxxx X. Xxxxxxx |
|
|
Name: Xxxxxxx X. Xxxxxxx |
|
|
Title: Executive Director |
|
| |
|
| |
|
For themselves and as Representatives (the “Representatives”) of the other Underwriters named herein |
Accepted and agreed: |
| |
|
| |
THE XXXX DISNEY COMPANY |
| |
|
| |
|
| |
By: |
/s/ Xxxxxxxx X. Xxxxxxx |
|
|
Name: Xxxxxxxx X. Xxxxxxx |
|
|
Title: SVP, Treasurer |
|
SCHEDULE I
September 17, 2015
Xxxxxxx, Sachs & Co.
X.X. Xxxxxx Securities LLC
As Representatives of the several Underwriters
Gentlemen:
I am Associate General Counsel of The Xxxx Disney Company, a Delaware corporation (“Disney”), and have acted as such in connection with the issuance and sale by Disney of Medium-Term Notes, Series F, entitled 1.500% Notes Due 2018 (the “2018 Notes”), 2.150% Notes Due 2020 (the “2020 Notes”) and the 3.150% Notes Due 2025 (the “2025 Notes” and, together with the 2018 Notes and 2020 Notes, the “Notes”) pursuant to the Terms Agreement, dated September 14, 2015 (the “Terms Agreement”), between Disney and each of Xxxxxxx, Xxxxx & Co. and X.X. Xxxxxx Securities LLC, as representatives of the several underwriters named therein (collectively, the “Underwriters”).
This letter is being furnished to you pursuant to the Terms Agreement.
In connection with this letter, I have examined and am familiar with originals or copies, certified or otherwise identified to my satisfaction, of such documents as I have deemed necessary or appropriate as a basis for this letter, including (a) the Registration Statement on Form S-3 (Registration No. 333-192690), filed with the Securities and Exchange Commission (the “Commission”) on December 6, 2013 (such Registration Statement (including the documents incorporated or deemed to be incorporated by reference in the Registration Statement or the Prospectus (as defined below) pursuant to Item 12 of Form S-3 under the Securities Act of 1933 (the “Incorporated Documents”)) being hereinafter referred to collectively as the “Registration Statement”), pertaining to Disney’s debt securities and other securities, (b) the Prospectus, dated December 6, 2013 (the “Base Prospectus”), the accompanying Prospectus Supplement, dated December 6, 2013 (the “Prospectus Supplement”) and the Pricing Supplement, dated September 14, 2015 (the “Pricing Supplement”), relating to the Notes, each of which was filed with the Commission pursuant to Rule 424(b) under the Securities Act of 1933 (such Base Prospectus (including the Incorporated Documents), Prospectus Supplement and Pricing Supplement being hereinafter referred to collectively as the “Prospectus”), (c) an executed copy of the Terms Agreement and (d) the Pricing Term Sheet dated September 14, 2015 filed with the Commission as a free writing prospectus pursuant to Rule 433 under the Securities Act of 1933 relating to the Notes (the “Term Sheet”).
I have made such inquiry of such officers of Disney and its subsidiaries and counsel for Disney and examined such corporate records, certificates of officers of Disney, officers of Disney’s subsidiaries and of public officials and such other documents and such questions of law and fact as I have considered necessary or appropriate for the purposes of this letter. In connection with my participation in the preparation of the Registration Statement, Prospectus and the Term Sheet, I have not verified, independently, nor do I pass upon or assume any responsibility for, explicitly or implicitly, the accuracy, completeness or fairness of the statements contained therein.
Based upon and subject to the foregoing, nothing has come to my attention that leads me to believe that (a) the Registration Statement at the time such Registration Statement became effective contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (b) the Pricing Disclosure Package, at the Applicable Time specified in the Terms Agreement, contained any untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, or (c) the Prospectus, as of the date of the Terms Agreement or as of the date hereof, contained or contains any untrue statement of a material fact or omitted or omits to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, except that, in each case, I express no opinion with respect to the financial statements, schedules and other financial data included or incorporated by reference therein or excluded therefrom or the exhibits to the Registration Statement, including the Trustee’s Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended. As used in this paragraph, “Pricing Disclosure Package” means the Base Prospectus (including the Incorporated Documents) and the accompanying Prospectus Supplement, together with the Term Sheet.
This letter is rendered to you and the Underwriters, in their capacity as Underwriters, in connection with the offering and sale of the Notes, and this letter may not be used, circulated, quoted or otherwise referred to or relied upon for any other purpose or by any other person without my prior express written permission.
|
Very truly yours, |
|
|
SCHEDULE II
Filed Pursuant to Rule 433
Registration No. 333-192690
Pricing Term Sheet
September 14, 2015
The Xxxx Disney Company
1.500% Notes Due 2018
2.150% Notes Due 2020
3.150% Notes Due 2025
This free writing prospectus relates only to the securities of The Xxxx Disney Company (the “Company”) described below and should be read together with the Company’s prospectus supplement dated December 6, 2013 (the “Prospectus Supplement”), the accompanying prospectus dated December 6, 2013 (the “Prospectus”) and the documents incorporated and deemed to be incorporated by reference therein.
Issuer: |
|
The Xxxx Disney Company |
|
|
|
Title of Securities: |
|
1.500% Notes Due 2018 (the “2018 Notes”) |
|
|
2.150% Notes Due 2020 (the “2020 Notes”) |
|
|
3.150% Notes Due 2025 (the “2025 Notes”) |
|
|
|
|
|
The 2018 Notes, 2020 Notes and 2025 Notes (collectively, the “Notes”) will be part of a single series of the Company’s senior debt securities under the indenture (as defined in the Prospectus Supplement) designated as Medium-Term Notes, Series F. The 2018 Notes, 2020 Notes and 2025 Notes are sometimes referred to, individually, as a “tranche” of Notes. |
|
|
|
Trade Date: |
|
September 14, 2015 |
|
|
|
Settlement Date (T+3): |
|
September 17, 2015 |
|
|
|
Maturity Date: |
|
2018 Notes: September 17, 2018 |
|
|
2020 Notes: September 17, 2020 |
|
|
2025 Notes: September 17, 2025 |
|
|
|
Aggregate Principal Amount |
|
2018 Notes: $500,000,000 |
Offered: |
|
2020 Notes: $750,000,000 |
|
|
2025 Notes: $750,000,000 |
|
|
|
Price to Public (Issue Price): |
|
2018 Notes: 99.915% plus accrued interest, if any, from September 17, 2015 |
|
|
2020 Notes: 99.750% plus accrued interest, if any, from September 17, 2015 |
|
|
2025 Notes: 99.762% plus accrued interest, if any, from September 17, 2015 |
|
|
|
Interest Rate: |
|
2018 Notes: 1.500% per annum, accruing from September 17, 2015 |
|
|
2020 Notes: 2.150% per annum, accruing from September 17, 2015 |
|
|
2025 Notes: 3.150% per annum, accruing from September 17, 2015 |
Interest Payment Dates: |
|
2018 Notes: Semi-annually on each March 17 and September 17, commencing on March 17, 2016 |
|
|
2020 Notes: Semi-annually on each March 17 and September 17, commencing on March 17, 2016 |
|
|
2025 Notes: Semi-annually on each March 17 and September 17, commencing on March 17, 2016 |
|
|
|
Regular Record Dates: |
|
2018 Notes: March 2 or September 2, as the case may be, immediately preceding the applicable interest payment date |
|
|
2020 Notes: March 2 or September 2, as the case may be, immediately preceding the applicable interest payment date |
|
|
2025 Notes: March 2 or September 2, as the case may be, immediately preceding the applicable interest payment date |
|
|
|
Use of Proceeds: |
|
The Company intends to use the net proceeds from the sale of the Notes for general corporate purposes, which may include among others, the general corporate purposes identified under the caption “Use of Proceeds” in the Prospectus. |
|
|
|
Proceeds to the Company: |
|
$1,988,915,000 (after deducting the underwriting discounts and commissions but before deducting estimated offering expenses payable by the Company). |
|
|
|
Underwriting Discounts and |
|
2018 Notes: 0.200% |
Commissions: |
|
2020 Notes: 0.350% |
|
|
2025 Notes: 0.450% |
|
|
|
CUSIP No.: |
|
2018 Notes: 00000XXX0 |
|
|
2020 Notes: 00000XXX0 |
|
|
2025 Notes: 00000XXX0 |
|
|
|
ISIN No.: |
|
2018 Notes: US25468PDD50 |
|
|
2020 Notes: US25468PDE34 |
|
|
2025 Notes: US25468PDF09 |
|
|
|
Optional Redemption: |
|
The Notes of any tranche may be redeemed, in whole or in part, at the option of the Company, at any time or from time to time prior to their stated maturity, at a redemption price equal to the greater of the following amounts: |
|
|
|
|
|
(1) 100% of the principal amount of the Notes of such tranche to be redeemed; or |
|
|
|
|
|
(2) as determined by the Independent Investment Banker (as defined below), the sum of the present values of the remaining scheduled payments of principal of and interest on the Notes of such tranche to be redeemed (not including any portion of any payments of interest accrued to the applicable redemption date) discounted to such redemption date on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined below) plus 10 basis points in the case of the 2018 Notes, 12.5 basis points in the case of the 2020 Notes or 15 basis points in the case of the 2025 Notes, plus, in the case of both clauses (1) and (2) above, accrued and unpaid interest on the principal amount of the Notes of such tranche being redeemed to such redemption date. |
|
|
Notwithstanding the foregoing, installments of interest on the Notes of any tranche that are due and payable on an interest payment date falling on or prior to a redemption date for the Notes of such tranche will be payable to the registered holders of such Notes (or one or more predecessor Notes of such tranche) of record at the close of business on the relevant regular record date, all as provided in the indenture. |
|
|
|
|
|
“Treasury Rate” means, with respect to any redemption date for the Notes of any tranche, the rate per annum equal to the semiannual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date. |
|
|
|
|
|
The Treasury Rate will be calculated on the third business day preceding the applicable redemption date. As used in the preceding sentence and in the definition of “Reference Treasury Dealer Quotation” below, the term “business day” means any day, other than a Saturday or Sunday, that is neither a legal holiday nor a day on which commercial banks are authorized or required by law, regulation or executive order to close in The City of New York. |
|
|
|
|
|
“Comparable Treasury Issue” means, with respect to any redemption date for the Notes of any tranche, the United States Treasury security selected by the Independent Investment Banker as having a maturity comparable to the remaining term of the Notes of such tranche that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such Notes. |
|
|
|
|
|
“Comparable Treasury Price” means, with respect to any redemption date for the Notes of any tranche, (i) if the Independent Investment Banker obtains four Reference Treasury Dealer Quotations for that redemption date, the average of those Reference Treasury Dealer Quotations after excluding the highest and lowest of those Reference Treasury Dealer Quotations, (ii) if the Independent Investment Banker obtains fewer than four but more than one such Reference Treasury Dealer Quotations, the average of all of those quotations, or (iii) if the Independent Investment Banker obtains only one such Reference Treasury Dealer Quotation, such quotation. |
|
|
|
|
|
“Independent Investment Banker” means one of Xxxxxxx, Sachs & Co., X.X. Xxxxxx Securities LLC, BNP Paribas Securities Corp. and Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated and their respective successors appointed by the Company to act as the Independent Investment Banker from time to time, or if any such firm is unwilling or unable to serve in that capacity, an independent investment banking institution of national standing appointed by the Company. |
|
|
“Reference Treasury Dealer” means, with respect to any redemption date for the Notes of any tranche, Xxxxxxx, Sachs & Co., X.X. Xxxxxx Securities LLC, BNP Paribas Securities Corp. and Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated and their respective successors; provided that, if any such firm ceases to be a primary U.S. Government securities dealer in the United States (a “Primary Treasury Dealer”), the Company will substitute another Primary Treasury Dealer. |
|
|
|
|
|
“Reference Treasury Dealer Quotation” means, with respect to each Reference Treasury Dealer and any redemption date for the Notes of any tranche, the average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Independent Investment Banker by such Reference Treasury Dealer at 5:00 p.m. (New York City time) on the third business day preceding that redemption date. |
|
|
|
|
|
Notice of any redemption will be mailed at least 30 days but not more than 60 days before the redemption date to each holder of the Notes of any tranche to be redeemed. If fewer than all of the Notes of any tranche and all Additional Notes (as defined in the Prospectus Supplement), if any, with the same stated maturity and other terms (other than original issue date, issue price and first payment of interest) as the Notes of such tranche are to be redeemed at any time, selection of such Notes and Additional Notes, if any, for redemption will be made by the trustee (as defined in the Prospectus Supplement) by such method as the trustee shall deem fair and appropriate. |
|
|
|
|
|
Unless the Company defaults in payment of the redemption price, interest on each Note or portion thereof called for redemption will cease to accrue on the applicable redemption date. |
|
|
|
No Additional Amounts or Tax Redemption: |
|
The provisions described in the Prospectus Supplement under the captions “Description of the Notes — Payment of Additional Amounts” and “Description of the Notes — Redemption for Tax Purposes” will not apply to the Notes. |
|
|
|
Form of Notes: |
|
The Notes of each tranche will be issued in the form of one or more global Notes in book-entry form and will be delivered to investors through the facilities of The Depository Trust Company for the accounts of its participants, which may include Clearstream Banking, société anonyme, and Euroclear Bank S.A./N.V., against payment. |
|
|
|
Currency: |
|
The Notes will be denominated and payable in U.S. dollars. |
|
|
|
Other: |
|
The Notes will not be entitled to the benefit of any sinking fund and the Company will not be required to repurchase Notes at the option of the holders. The Notes are “fixed rate notes” as defined in the Prospectus Supplement. |
|
|
|
Material United States Federal Income Tax Considerations: |
|
For a discussion of the material United States federal income tax considerations related to the acquisition, ownership and disposition of the Notes, please see “Material United States Federal Income Tax Considerations” in the Prospectus Supplement, as supplemented by the discussion in the immediately following paragraph captioned “Backup Withholding Rates.” |
|
|
Backup Withholding Rates |
|
|
|
|
|
The backup withholding rate is currently 28% for payments on the Notes (including gross proceeds from a sale of the Notes) that are subject to backup withholding. The backup withholding rate did not increase to 31% for payments made after December 31, 2010. |
|
|
|
Joint Bookrunning Managers: |
|
Xxxxxxx, Xxxxx & Co. |
|
|
X.X. Xxxxxx Securities LLC |
|
|
BNP Paribas Securities Corp. |
|
|
Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx |
|
|
Incorporated |
|
|
|
Co-Managers: |
|
Lloyds Securities Inc. |
|
|
SMBC Nikko Securities America, Inc. |
|
|
U.S. Bancorp Investments, Inc. |
|
|
The Xxxxxxxx Capital Group, L.P. |
|
|
|
Junior Co-Managers: |
|
Xxxxxx & Company |
|
|
Lebenthal & Co., LLC |
|
|
Xxxxxx X. Xxxxxxx & Company, Inc. |
|
|
Xxxxxxx Xxxxxxxxx Xxxxx & Co., L.L.C. |
Pursuant to a terms agreement dated the date hereof, the joint bookrunning managers, co-managers and junior co-managers (collectively, the “underwriters”) named above, acting as principal, have severally agreed to purchase the Notes from the Company. The several obligations of the underwriters to purchase the Notes are subject to conditions and they are obligated to purchase all of the Notes if any are purchased. If an underwriter defaults, the terms agreement provides that the purchase commitments of the non-defaulting underwriters may be increased or the terms agreement may be terminated.
The Company estimates that expenses of the offering payable by the Company, excluding underwriting discounts and commissions, will be approximately $1,040,000.
European Economic Area. This free writing prospectus is not a prospectus for purposes of the Prospectus Directive (as defined below) as implemented in Member States of the European Economic Area. Neither the Company nor the underwriters have authorized, nor does the Company or the underwriters authorize, the making of any offer of the Notes through any financial intermediary other than offers made by the underwriters which constitute the final placement of the Notes contemplated in this free writing prospectus. In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a “Relevant Member State”), each underwriter has severally represented and agreed that with effect from and including the date on which the Prospectus Directive is implemented in that Relevant Member State (the “Relevant Implementation Date”) it has not made and will not make an offer of Notes which are the subject of the offering contemplated hereby to the public in that Relevant Member State except that it may, with effect from and including the Relevant Implementation Date, make an offer of such Notes to the public in that Relevant Member State at any time:
(a) to any legal entity which is a qualified investor as defined in the Prospectus Directive;
(b) to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Directive), subject to obtaining the prior consent of the representatives of the underwriters for any such offer; or
(c) in any other circumstances falling within Article 3(2) of the Prospectus Directive,
provided that no such offer of Notes referred to in (a) through (c) above shall require the Company or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Directive, or supplement a prospectus pursuant to Article 16 of the Prospectus Directive.
For the purposes of this provision, the expression an “offer of Notes to the public” in relation to any Notes in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the Notes to be offered so as to enable an investor to decide to purchase or subscribe for the Notes, as the same may be varied in that Relevant Member State by any measure implementing the Prospectus Directive in that Relevant Member State and the expression “Prospectus Directive” means Directive 2003/71/EC (and amendments thereto, including Directive 2010/73/EU) and includes any relevant implementing measure in the Relevant Member State.
United Kingdom. Each underwriter severally has represented and agreed that:
· it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Xxx 0000 (the “FSMA”)) received by it in connection with the issue or sale of the Notes in circumstances in which Section 21(1) of the FSMA does not apply to the Company; and
· it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the Notes in, from or otherwise involving the United Kingdom.
Hong Kong. The Notes may not be offered or sold in Hong Kong by means of any document other than (i) in circumstances which do not constitute an offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32 of the Laws of Hong Kong) (“Companies (Winding Up and Miscellaneous Provisions) Ordinance”) or which do not constitute an invitation to the public within the meaning of the Securities and Futures Ordinance Ordinance (Cap. 571 of the Laws of Hong Kong) (“Securities and Futures Ordinance”), or (ii) to “professional investors” as defined in the Securities and Futures Ordinance and any rules made thereunder, or (iii) in other circumstances which do not result in the document being a “prospectus” as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance, and no advertisement, invitation or document relating to the Notes may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to Notes which are or are intended to be disposed of only to persons outside Hong Kong or only to “professional investors” in Hong Kong as defined in the Securities and Futures Ordinance and any rules made thereunder.
Singapore. The Prospectus Supplement, the Prospectus and this term sheet have not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, the Prospectus Supplement, the Prospectus and this term sheet and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the Notes may not be circulated or distributed, nor may the Notes be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor (as defined in Section 4A of the Securities and Futures Act, Chapter 289 of Singapore (the “SFA”)) under Section 274 of the SFA, (ii) to a relevant person (as defined in Section 275(2) of the SFA ) pursuant to Section 275(1) of the SFA, or any person pursuant to Section 275(1A) of the SFA, and in accordance with the conditions specified in Section 275 of the SFA or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA, in each case subject to conditions set forth in the SFA.
Where the Notes are subscribed or purchased under Section 275 of the SFA by a relevant person which is a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor, the securities (as defined in Section 239(1) of the SFA) of that corporation shall not be transferable for 6 months after that corporation has acquired the Notes under Section 275 of the SFA except: (1) to an institutional investor under Section 274 of the SFA or to a relevant person (as defined in Section 275(2) of the SFA), (2) where such transfer arises from an offer in that corporation’s securities pursuant to Section 275(1A) of the SFA, (3) where no consideration is or will be given for the transfer, (4) where the transfer is by operation of law, (5) as specified in Section 276(7) of the SFA, or (6) as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures) Regulations 2005 of Singapore (“Regulation 32”).
Where the Notes are subscribed or purchased under Section 275 of the SFA by a relevant person which is a trust (where the trustee is not an accredited investor (as defined in Section 4A of the SFA)) whose sole purpose is to hold investments and each beneficiary of the trust is an accredited investor, the beneficiaries’ rights and interest (howsoever described) in that trust shall not be transferable for 6 months after that trust has acquired the Notes under Section 275 of the SFA except: (1) to an institutional investor under Section 274 of the SFA or to a relevant person (as defined in Section 275(2) of the SFA), (2) where such transfer arises from an offer that is made on terms that such rights or interest are acquired at a consideration of not less than S$200,000 (or its equivalent in a foreign currency) for each transaction (whether such amount is to be paid for in cash or by exchange of securities or other assets), (3) where no consideration is or will be given for the transfer, (4) where the transfer is by operation of law, (5) as specified in Section 276(7) of the SFA, or (6) as specified in Regulation 32.
Japan. The Notes have not been and will not be registered under the Financial Instruments and Exchange Act of Japan (Act No. 25 of 1948, as amended), or the FIEA. The Notes may not be offered or sold, directly or indirectly, in Japan or to or for the benefit of any resident of Japan (including any person resident in Japan or any corporation or other entity organized under the laws of Japan) or to others for reoffering or resale, directly or indirectly, in Japan or to or for the benefit of any resident of Japan, except pursuant to an exemption from the registration requirements of the FIEA and otherwise in compliance with any relevant laws and regulations of Japan.
The issuer has filed a Registration Statement (including a prospectus) with the Securities and Exchange Commission for the offering to which this communication relates. Before you invest, you should read the prospectus and prospectus supplement in that registration statement and other documents the issuer has filed with the Securities and Exchange Commission for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC website at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by contacting Xxxxxxx, Sachs & Co. by telephone (toll free) at 0-000-000-0000 or X.X. Xxxxxx Securities LLC by telephone (collect) at 0-000-000-0000.